Smith+Nephew announced the US launch of its next generation LEAF Patient Monitoring System, a cloud-based platform designed to prevent hospital-acquired pressure injuries (HAPIs). The system uses wearable sensors to monitor patient mobility and improve turning protocol adherence. According to the company, the LEAF system monitors over 150,000 patients annually, reduces HAPI odds by up to 73%, and delivers up to $1.8 million in estimated savings per critical care facility.

Smith+Nephew is launching two new wound care products at the European Wound Management Association Conference in May 2026: ALLEVYN COMPLETE CARE Foam Dressing with enhanced exudate management and pressure ulcer prevention, and RENASYS EDGE Negative Pressure Wound Therapy System designed for simplicity and patient compliance. The launches address the significant healthcare challenge of chronic wounds affecting 14.9 million people in Europe.

The global wound cleanser products market is valued at USD 3.22 billion in 2025 and is projected to reach USD 5.17 billion by 2035, growing at a CAGR of 4.92%. Growth is driven by rising chronic wounds, surgical procedures, and demand for advanced antimicrobial cleansing solutions. The U.S. market is expected to grow from USD 0.99 billion to USD 1.49 billion during the same period. Saline-based cleansers dominate with 37.55% market share, while antimicrobial cleansers are expected to grow fastest at 6.18% CAGR.

The global tissue engineering market is projected to grow from USD 15.01 billion in 2026 to USD 27.59 billion by 2031, driven by advancements in regenerative medicine, biomaterials, and stem cell research. Key growth drivers include increasing demand for regenerative therapies, innovations in 3D bioprinting, rising prevalence of chronic diseases, and expanding applications in orthopedics, skin regeneration, and dental restoration. North America leads the market while Asia-Pacific emerges as a high-growth region.

The global surgical drill bits market was valued at USD 316 million in 2025 and is projected to reach USD 540 million by 2035, growing at a CAGR of 5.5%. Growth is driven by healthcare infrastructure development in emerging economies, increased surgical procedures, and rising demand for infection prevention measures. Hospitals are expected to dominate the market segment, while North America leads in market share and Asia-Pacific shows the highest growth rate.

The global foot and ankle devices market is projected to grow from USD 5.9 billion in 2025 to USD 9.2 billion by 2034, driven by rising incidence of foot and ankle conditions, diabetes-related complications, aging populations, and technological advancements in minimally invasive procedures and 3D-printed implants. North America leads the market, with key players including DePuy Synthes, Stryker, and Zimmer Biomet driving innovation through recent product launches and strategic developments.

The global ambulatory surgical equipment market is valued at USD 7.39 billion in 2026 and is expected to reach USD 14.58 billion by 2035, growing at a 7.85% CAGR. North America dominates with 34% market share, while Asia Pacific is the fastest-growing region. Endoscopy and laparoscopy systems lead by product type at 18% share, with compact intraoperative imaging expected to grow fastest. Independent ambulatory surgical centers account for 42% of the market.

The global surgical stapling devices market was valued at USD 5.47 billion in 2025 and is projected to reach USD 10.14 billion by 2035, growing at a 7.2% CAGR. Growth is driven by increasing surgical volumes, adoption of minimally invasive and robotic procedures, rising obesity and colorectal disease prevalence, and technological innovations in powered stapling systems. North America leads the market while Asia Pacific shows the fastest growth.

Smith+Nephew announced it will showcase advanced orthopaedic technologies at AAOS 2026, including its CORI handheld robotic surgical system for hip, knee and shoulder arthroplasty, new trauma solutions like the EVOS plating system, and an expanded ASC portfolio. The company also announced distribution agreements with SI-BONE for pelvic fracture solutions and RMR Ortho for nitinol fixation technology.

Smith+Nephew will showcase its rotator cuff repair portfolio at AAOS 2026, featuring the newly acquired Tendon Seam Repair System and REGENETEN Bioinductive Implant. The company also announced exclusive US distribution agreements with RMR Ortho for A'TOMIC nitinol fixation technology and SI-BONE for their iFuse TORQ portfolio, expanding its orthopedic offerings.

The global scar treatment market is projected to grow from USD 26.60 billion in 2025 to USD 56.30 billion by 2033, with a CAGR of 9.91%. Growth is driven by increasing awareness of advanced cosmetic and reconstructive procedures, rising prevalence of acne, surgical, and traumatic scars, and technological advancements in minimally invasive treatments. The U.S. market alone is expected to reach USD 17.69 billion by 2033.

The global anti-biofilm agents market is experiencing robust growth driven by escalating hospital-acquired infections (13% higher than pre-pandemic levels), rising antimicrobial resistance, and increasing prevalence of chronic wounds among the 589 million diabetic population. Key growth drivers include FDA regulatory support, industrial water treatment demand, and hospital adoption of advanced biofilm-disrupting technologies. Dressings and silver-based solutions dominate the market, with North America leading regionally and Asia Pacific showing fastest growth.